Novantrone
Showing 1 - 25 of 73
Acute Myeloid Leukemia Trial in Memphis (Venetoclax, Azacitidine, Cytarabine)
Not yet recruiting
- Acute Myeloid Leukemia
- Venetoclax
- +9 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jul 21, 2023
Acute Myeloid Leukemia Trial (Gilteritinib 40 MG Oral Tablet, Cladribine, Cytarabine)
Not yet recruiting
- Acute Myeloid Leukemia
- Gilteritinib 40 MG Oral Tablet
- +4 more
-
Lexington, KentuckyUniversity of Kentucky
Oct 27, 2022
Relapsed Adult AML, Refractory AML Trial in Milwaukee (Navitoclax Dose Level -1, Navitoclax Dose Level 0, Navitoclax Dose Level
Not yet recruiting
- Relapsed Adult AML
- Refractory AML
- Navitoclax Dose Level -1
- +10 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Aug 17, 2023
Prostate Cancer Patients Trial in Qingdao, Shanghai (Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin)
Recruiting
- Prostate Cancer Patients
- Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin
-
Qingdao, Shandong, China
- +1 more
May 3, 2022
Non-Hodgkins Lymphoma Trial in Fort Myers, Nashville (Cyclophosphamide, Mitoxantrone, Vincristine)
Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma Trial in San Diego,
Completed
- Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia
- Recurrent Childhood B-Lymphoblastic Lymphoma
- dexamethasone
- +18 more
-
San Diego, California
- +2 more
Sep 13, 2022
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoblastic Lymphoma Trial in Valhalla, Charlotte (Clofarabine,
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +4 more
-
Valhalla, New York
- +1 more
Oct 29, 2021
Acute Myeloid Leukemia Trial in Seattle (drug, biological, other)
Active, not recruiting
- Acute Myeloid Leukemia
- Cladribine
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 10, 2022
Multiple Sclerosis Trial in Isfahan (plasmapheresis)
Completed
- Multiple Sclerosis
- plasmapheresis
-
Isfahan, Iran, Islamic Republic ofAlahra hospital
Aug 27, 2020
Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (drug, biological, other)
Completed
- Acute Leukemia of Ambiguous Lineage
- +2 more
- Cladribine
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Feb 23, 2022
Lymphoma Trial in Houston (Fludarabine, Novantrone, Decadron)
Completed
- Lymphoma
- Fludarabine
- +14 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 22, 2020
Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia Trial in
Recruiting
- Recurrent Adult Acute Myeloid Leukemia
- +2 more
- Sirolimus
- +3 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Dec 7, 2020
Acute Lymphoblastic Leukemia Trial in Canada, United States (ITMHA, Dexamethasone, Mitoxantrone)
Active, not recruiting
- Acute Lymphoblastic Leukemia
- ITMHA
- +13 more
-
Los Angeles, California
- +17 more
Jun 6, 2022
Acute Myeloid Leukemia Trial in Houston (Crenolanib besylate, Idarubicin, Cytarabine)
Completed
- Acute Myeloid Leukemia
- Crenolanib besylate
- +7 more
-
Houston, TexasMD Anderson Cancer Center
Jul 17, 2020
Follicular Lymphoma Trial in Houston (Bendamustine, Mitoxantrone, Rituximab)
Terminated
- Follicular Lymphoma
- Bendamustine
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Apr 1, 2020
Blasts 10 Percent or More of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia-2, High Grade Malignant Tumor Trial in
Completed
- Blasts 10 Percent or More of Bone Marrow Nucleated Cells
- +8 more
- Cladribine
- +13 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 11, 2021
Acute Lymphoblastic Leukemia, Precursor B-Cell Lymphoblastic Leukemia, Precursor T-Cell Lymphoblastic Leukemia Trial in
Terminated
- Acute Lymphoblastic Leukemia
- +2 more
- Decitabine
- +6 more
-
Los Angeles, California
- +27 more
Oct 5, 2020
Neuromyelitis Optica, Myelitis, Transverse, Demyelinating Autoimmune Diseases, CNS Trial in Buffalo (Mitoxantrone)
Completed
- Neuromyelitis Optica
- +3 more
-
Buffalo, New YorkBaird Multiple Sclerosis Center
Dec 23, 2020
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial
Completed
- Adult Acute Megakaryoblastic Leukemia (M7)
- +16 more
- azacitidine
- +3 more
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
May 13, 2020
Acute Myeloid Leukemia, MDS Trial in Boston (Prexasertib, Mitoxantrone, Etoposide)
Terminated
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Prexasertib
- +3 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jun 10, 2019
Mixed Phenotype Acute Leukemia, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia Trial in
Completed
- Mixed Phenotype Acute Leukemia
- +6 more
- Cladribine
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Feb 21, 2020
Chronic Lymphocytic Leukemia Trial in Houston (Fludarabine, Cyclophosphamide, Mitoxantrone)
Completed
- Chronic Lymphocytic Leukemia
- Fludarabine
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Apr 18, 2019
Acute Biphenotypic Leukemia, de Novo Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome Trial in Seattle
Completed
- Acute Biphenotypic Leukemia
- +5 more
- Cladribine
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 26, 2019
Childhood Acute Promyelocytic Leukemia (M3), Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Trial in
Active, not recruiting
- Childhood Acute Promyelocytic Leukemia (M3)
- Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
- arsenic trioxide
- +7 more
-
Birmingham, Alabama
- +110 more
Mar 23, 2022